Clinical trials
Sleep Apnea, Obstructive trials in Germany
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
66 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2006 | 1 |
| 2008 | 4 |
| 2009 | 2 |
| 2010 | 2 |
| 2011 | 3 |
| 2012 | 3 |
| 2013 | 3 |
| 2014 | 5 |
| 2015 | 9 |
| 2016 | 6 |
| 2017 | 3 |
| 2018 | 3 |
| 2019 | 6 |
| 2020 | 2 |
| 2021 | 1 |
| 2022 | 1 |
| 2024 | 3 |
| 2025 | 5 |
| 2026 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 39 |
| Terminated | 7 |
| Unknown status | 7 |
| Recruiting | 5 |
| Active, not recruiting | 5 |
| Withdrawn | 2 |
| Enrolling by invitation | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| ResMed | 7 |
| Inspire Medical Systems, Inc. | 5 |
| Fisher and Paykel Healthcare | 4 |
| Institut für Pneumologie Hagen Ambrock eV | 4 |
| Wissenschaftliches Institut Bethanien e.V | 4 |
| Jazz Pharmaceuticals | 3 |
| Nyxoah S.A. | 3 |
| Amgen | 2 |
| CENTOGENE GmbH Rostock | 2 |
| Eli Lilly and Company | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Sleep Apnea, Obstructive | 66 |
| Sleep Apnea Syndromes | 11 |
| Sleep Apnea, Central | 8 |
| Obesity | 6 |
| Heart Failure | 4 |
| Overweight | 4 |
| Cheyne-Stokes Respiration | 2 |
| Disorders of Excessive Somnolence | 2 |
| Lung Diseases | 2 |
| Macroglossia | 2 |
Trials
Showing 26 to 50 of 66. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.